82 related articles for article (PubMed ID: 9430873)
21. Dose-related reversal of acute lung rejection by aerosolized cyclosporine.
Iacono AT; Smaldone GC; Keenan RJ; Diot P; Dauber JH; Zeevi A; Burckart GJ; Griffith BP
Am J Respir Crit Care Med; 1997 May; 155(5):1690-8. PubMed ID: 9154878
[TBL] [Abstract][Full Text] [Related]
22. Decreased urinary epidermal growth factor in children with acute renal failure: epidermal growth factor/creatinine ratio not a reliable parameter for urinary epidermal growth factor excretion.
Tsau YK; Sheu JN; Chen CH; Teng RJ; Chen HC
Pediatr Res; 1996 Jan; 39(1):20-24. PubMed ID: 8825381
[TBL] [Abstract][Full Text] [Related]
23. A role for leukotrienes in cyclosporine nephrotoxicity.
Butterly DW; Spurney RF; Ruiz P; Griffiths R; Albrightson C; Coffman TM
Kidney Int; 2000 Jun; 57(6):2586-93. PubMed ID: 10844628
[TBL] [Abstract][Full Text] [Related]
24. Cyclosporine or FK506 decrease mature epidermal growth factor protein expression and renal tubular regeneration in rat kidneys with ischemia/reperfusion injury.
Yang CW; Lee SH; Lim SW; Jung JY; Kim WY; Kim HW; Choi BS; Li C; Cha JH; Kim YS; Kim J; Bang BK
Nephron; 2002 Dec; 92(4):914-21. PubMed ID: 12399639
[TBL] [Abstract][Full Text] [Related]
25. The impact of age on rejection in kidney transplantation.
de Fijter JW
Drugs Aging; 2005; 22(5):433-49. PubMed ID: 15903355
[TBL] [Abstract][Full Text] [Related]
26. Urinary epidermal growth factor excretion is correlated to renal function loss per se and not to the degree of diabetic renal failure.
ter Meulen CG; Bilo HJ; van Kamp GJ; Gans RO; Donker AJ
Neth J Med; 1994 Jan; 44(1):12-7. PubMed ID: 8202200
[TBL] [Abstract][Full Text] [Related]
27. Transforming growth factor-β activated long non-coding RNA ATB plays an important role in acute rejection of renal allografts and may impacts the postoperative pharmaceutical immunosuppression therapy.
Qiu J; Chen Y; Huang G; Zhang Z; Chen L; Na N
Nephrology (Carlton); 2017 Oct; 22(10):796-803. PubMed ID: 27414253
[TBL] [Abstract][Full Text] [Related]
28. Influence of kidney or heart transplantation on the urinary excretion of epidermal growth factor.
Amado JA; De-Francisco AL; Botana MA; Pesquera C; Vázquez-de-Prada JA; Arias M
Transpl Int; 1994; 7(2):127-30. PubMed ID: 8179800
[TBL] [Abstract][Full Text] [Related]
29. Distinct expression of interleukin 17, tumor necrosis factor α, transforming growth factor β, and forkhead box P3 in acute rejection after kidney transplantation.
de Menezes Neves PD; Machado JR; dos Reis MA; Faleiros AC; de Lima Pereira SA; Rodrigues DB
Ann Diagn Pathol; 2013 Feb; 17(1):75-9. PubMed ID: 22963863
[TBL] [Abstract][Full Text] [Related]
30. Urinary excretion of epidermal growth factor in living human kidney donors and their recipients.
Jørgensen PE; Kamper AL; Munck O; Strandgaard S; Nexø E
Eur J Clin Invest; 1995 Jun; 25(6):442-6. PubMed ID: 7656924
[TBL] [Abstract][Full Text] [Related]
31. Noninvasive detection of acute renal allograft rejection by measurement of soluble Tim-3 in urine.
Chen D; Peng W; Jiang H; Yang H; Wu J; Wang H; Chen J
Mol Med Rep; 2017 Jul; 16(1):915-921. PubMed ID: 28586044
[TBL] [Abstract][Full Text] [Related]
32. Epidermal growth factor in urine after kidney transplantation in humans.
Kvist N; Nexø E
Urol Res; 1989; 17(4):255-8. PubMed ID: 2672532
[TBL] [Abstract][Full Text] [Related]
33. Interleukin-6 expression after renal transplantation.
Waiser J; Budde K; Katalinic A; Kuerzdörfer M; Riess R; Neumayer HH
Nephrol Dial Transplant; 1997 Apr; 12(4):753-9. PubMed ID: 9141007
[TBL] [Abstract][Full Text] [Related]
34. Genetic association of interleukin-2, interleukin-4, interleukin-6, transforming growth factor-β, tumour necrosis factor-α and blood concentrations of calcineurin inhibitors in Turkish renal transplant patients.
Seyhun Y; Ciftci HS; Kekik C; Karadeniz MS; Tefik T; Nane I; Turkmen A; Oguz FS; Aydin F
Int J Immunogenet; 2015 Jun; 42(3):147-60. PubMed ID: 25817300
[TBL] [Abstract][Full Text] [Related]
35. Temporal changes of cytokines and nitric oxide products in urine from renal transplant patients.
Smith SD; Wheeler MA; Lorber MI; Weiss RM
Kidney Int; 2000 Aug; 58(2):829-37. PubMed ID: 10916108
[TBL] [Abstract][Full Text] [Related]
36. Osteopontin expression in acute renal allograft rejection.
Alchi B; Nishi S; Kondo D; Kaneko Y; Matsuki A; Imai N; Ueno M; Iguchi S; Sakatsume M; Narita I; Yamamoto T; Gejyo F
Kidney Int; 2005 Mar; 67(3):886-96. PubMed ID: 15698428
[TBL] [Abstract][Full Text] [Related]
37. -174G/C interleukin-6 gene polymorphism and the risk of transplanted kidney failure or graft loss during a 5-year follow-up period.
Kocierz M; Siekiera U; Kolonko A; Karkoszka H; Chudek J; Cierpka L; Wiȩcek A
Tissue Antigens; 2011 Apr; 77(4):283-90. PubMed ID: 21388350
[TBL] [Abstract][Full Text] [Related]
38. Renal content and output of epidermal growth factor in long-term adrenergic agonist-treated rats.
Thulesen J; Nexø E; Poulsen SS
Regul Pept; 2000 Jun; 90(1-3):69-76. PubMed ID: 10828495
[TBL] [Abstract][Full Text] [Related]
39. Effect of angiotensin-converting enzyme inhibition on growth factor mRNA in chronic renal allograft rejection in the rat.
Szabo A; Lutz J; Schleimer K; Antus B; Hamar P; Philipp T; Heemann U
Kidney Int; 2000 Mar; 57(3):982-91. PubMed ID: 10720951
[TBL] [Abstract][Full Text] [Related]
40. Increased epidermal growth factor in experimental diabetes related kidney growth in rats.
Gilbert RE; Cox A; McNally PG; Wu LL; Dziadek M; Cooper ME; Jerums G
Diabetologia; 1997 Jul; 40(7):778-85. PubMed ID: 9243098
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
